These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 1477386)
1. Cohort study of HIV-positive and HIV-negative tuberculosis, Nairobi, Kenya: comparison of bacteriological results. Githui W; Nunn P; Juma E; Karimi F; Brindle R; Kamunyi R; Gathua S; Gicheha C; Morris J; Omwega M Tuber Lung Dis; 1992 Aug; 73(4):203-9. PubMed ID: 1477386 [TBL] [Abstract][Full Text] [Related]
2. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda. Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516 [TBL] [Abstract][Full Text] [Related]
3. The impact of human immunodeficiency virus on response to treatment and recurrence rate in patients treated for tuberculosis: two-year follow-up of a cohort in Lusaka, Zambia. Elliott AM; Halwiindi B; Hayes RJ; Luo N; Mwinga AG; Tembo G; Machiels L; Steenbergen G; Pobee JO; Nunn PP J Trop Med Hyg; 1995 Feb; 98(1):9-21. PubMed ID: 7861484 [TBL] [Abstract][Full Text] [Related]
4. Under-diagnosis of smear-positive pulmonary tuberculosis in Nairobi, Kenya. Hawken MP; Muhindi DW; Chakaya JM; Bhatt SM; Ng'ang'a LW; Porter JD Int J Tuberc Lung Dis; 2001 Apr; 5(4):360-3. PubMed ID: 11334255 [TBL] [Abstract][Full Text] [Related]
5. The impact of human immunodeficiency virus on presentation and diagnosis of tuberculosis in a cohort study in Zambia. Elliott AM; Halwiindi B; Hayes RJ; Luo N; Tembo G; Machiels L; Bem C; Steenbergen G; Pobee JO; Nunn PP J Trop Med Hyg; 1993 Feb; 96(1):1-11. PubMed ID: 8429569 [TBL] [Abstract][Full Text] [Related]
6. Aspects of tuberculosis in Africa. 2. The value of microbiology in the management of tuberculosis in Nairobi, Kenya. Brindle R Trans R Soc Trop Med Hyg; 1992; 86(5):470-1. PubMed ID: 1475805 [TBL] [Abstract][Full Text] [Related]
7. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy. Swaminathan S; Deivanayagam CN; Rajasekaran S; Venkatesan P; Padmapriyadarsini C; Menon PA; Ponnuraja C; Dilip M Natl Med J India; 2008; 21(1):3-8. PubMed ID: 18472696 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of anti-tuberculosis treatment among patients receiving highly active antiretroviral therapy at Vihiga district hospital in 2007. Kwange SO; Budambula NL Indian J Med Microbiol; 2010; 28(1):21-5. PubMed ID: 20061758 [TBL] [Abstract][Full Text] [Related]
9. Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya. Analysis of early (6-month) mortality. Nunn P; Brindle R; Carpenter L; Odhiambo J; Wasunna K; Newnham R; Githui W; Gathua S; Omwega M; McAdam K Am Rev Respir Dis; 1992 Oct; 146(4):849-54. PubMed ID: 1416409 [TBL] [Abstract][Full Text] [Related]
10. Should we take a history of prior treatment, and check sputum status at 2-3 months when treating patients for tuberculosis? Wilkinson D; Bechan S; Connolly C; Standing E; Short GM Int J Tuberc Lung Dis; 1998 Jan; 2(1):52-5. PubMed ID: 9562111 [TBL] [Abstract][Full Text] [Related]
11. The new tuberculosis. De Cock K Afr Health; 1994 Mar; 16(3):8-10. PubMed ID: 12318774 [TBL] [Abstract][Full Text] [Related]
12. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [TBL] [Abstract][Full Text] [Related]
13. An approach to the problems of diagnosing and treating adult smear-negative pulmonary tuberculosis in high-HIV-prevalence settings in sub-Saharan Africa. Harries AD; Maher D; Nunn P Bull World Health Organ; 1998; 76(6):651-62. PubMed ID: 10191561 [TBL] [Abstract][Full Text] [Related]
14. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis]. Wada M; Yosiyama T; Yosikawa M; Ogata H; Sugie T; Nakasono T; Sugita H Kekkaku; 1994 Nov; 69(11):671-80. PubMed ID: 7837720 [TBL] [Abstract][Full Text] [Related]
15. The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia. Elliott AM; Halwiindi B; Hayes RJ; Luo N; Mwinga AG; Tembo G; Machiels L; Steenbergen G; Pobee JO; Nunn P Trans R Soc Trop Med Hyg; 1995; 89(1):78-82. PubMed ID: 7747316 [TBL] [Abstract][Full Text] [Related]
17. [Bacteriological examination on needle biopsy specimens of cavity and tuberculoma after a short course chemotherapy in initially sputum positive pulmonary tuberculosis patients]. Lu SH; Wang TP; Lü W; Du RH; Wang HX; Wang ZR Zhonghua Jie He He Hu Xi Za Zhi; 2006 Dec; 29(12):832-4. PubMed ID: 17327088 [TBL] [Abstract][Full Text] [Related]
18. Severe cutaneous hypersensitivity reactions during treatment of tuberculosis in patients with HIV infection in Tanzania. Dukes CS; Sugarman J; Cegielski JP; Lallinger GJ; Mwakyusa DH Trop Geogr Med; 1992 Oct; 44(4):308-11. PubMed ID: 1284179 [TBL] [Abstract][Full Text] [Related]
19. A case control study on human immunodeficiency virus-1 (HIV-1) infection as a risk factor for tuberculosis and leprosy in western Kenya. Orege PA; Fine PE; Lucas SB; Obura M; Okelo C; Okuku P; Were M Tuber Lung Dis; 1993 Dec; 74(6):377-81. PubMed ID: 8136490 [TBL] [Abstract][Full Text] [Related]
20. Initial resistance to antituberculosis drugs in Yaounde, Cameroon in 1995. Bercion R; Kuaban C Int J Tuberc Lung Dis; 1997 Apr; 1(2):110-4. PubMed ID: 9441073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]